Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.810
+0.030 (0.79%)
Aug 6, 2026, 9:43 AM EDT - Market open
Opus Genetics Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Opus Genetics stock has a consensus rating of "Strong Buy" and an average price target of $10.61. The average 1-year stock price forecast is 178.48% higher than the current stock price, while the lowest is $8.00 (+109.97%) and the highest is $16 (+319.95%).
Price Target: $10.61 (+178.48%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Opus Genetics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 13 | 14 | 15 | 16 | 16 |
| Buy | 1 | 2 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 16 | 18 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $12 | Buy | Maintains | $12 | +214.96% | Aug 4, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +162.47% | Aug 3, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $10 | Buy | Maintains | $10 | +162.47% | Jul 30, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 29, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $15 | Buy | Maintains | $15 | +293.70% | Jul 10, 2026 |
Financial Forecast
Revenue This Year
14.87M
from 14.20M
Increased by 4.75%
Revenue Next Year
14.64M
from 14.87M
Decreased by -1.55%
EPS This Year
-1.02
from -0.80
EPS Next Year
-0.77
from -1.02
EPS and Forward PE are based on non-GAAP adjusted numbers.